DUSP1 and metabolic dysfunction-associated steatotic liver disease: In patients with MASLD undergoing liver surgery, a significant upregulation of miR-200c-3p has been observed, indicating a potential protective role through the modulation of dual-specificity protein phosphatase 1 (DUSP1) expression and MAPK activity.